The tau PET result was not associated with a change in diagnoses in the Aβ-negative group (6 participants changed from pre-PET AD to post-PET non-AD and 1 from a pre-PET non-AD diagnosis to post-PET AD; McNemar test, P = .13). Here, MAPT is linked to Alzheimer disease.